Zhiwei Liao | Biochemistry | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

Zhiwei Liao
Huazhong University of Science and Technology, China

Zhiwei Liao
Affiliation Huazhong University of Science and Technology
Country China
Scopus ID 57256472800
Documents 65
Citations 3,364
h-index 31
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards
ORCID 0000-0002-6723-2522

The Best Researcher Award recognizes researchers whose scholarly work demonstrates research productivity, scientific contribution, and measurable engagement with the academic literature. Zhiwei Liao is presented in this article through the supplied research-profile information, with an institutional affiliation at Huazhong University of Science and Technology in China. The profile identifies Biochemistry, Genetics and Molecular Biology as the relevant subject area and provides Scopus and ORCID identifiers for further reference. These records offer starting points for examining scholarly activity and researcher identity. (1) (2)

Abstract

This article outlines the research profile of Zhiwei Liao in the broad field of Biochemistry, Genetics and Molecular Biology. The supplied Scopus metrics report 65 documents, 3,364 citations, and an h-index of 31. These indicators provide quantitative context for evaluating publication activity and citation visibility, but they do not independently establish the quality, originality, or practical significance of individual studies. The ORCID record provides a persistent researcher identifier that can help distinguish the researcher from others with similar names. (1) (2)

Keywords

  • Best Researcher Award
  • Zhiwei Liao
  • Biochemistry
  • Genetics and molecular biology
  • Research impact
  • Scholarly publications
  • Researcher identifiers

Introduction

Academic recognition programs commonly assess research through a combination of scholarly output, field relevance, research quality, originality, and wider contribution. Bibliographic databases help organize publications and citation information, while persistent identifiers support reliable attribution of research outputs. Scopus and ORCID serve different but complementary purposes: Scopus presents indexed publication and citation information, whereas ORCID provides a persistent identifier and researcher-maintained record. (1) (2)

Research Profile

The supplied profile associates Zhiwei Liao with Huazhong University of Science and Technology, China, and identifies Biochemistry, Genetics and Molecular Biology as the subject area. The provided Scopus author identifier is 57256472800, and the ORCID iD is 0000-0002-6723-2522. The supplied metrics—65 documents, 3,364 citations, and an h-index of 31—should be treated as profile data provided for this article and checked against the live database before publication. (1) (2)

Research Contributions

Biochemistry, genetics, and molecular biology encompass the investigation of biological molecules, genetic processes, cellular mechanisms, and interactions that influence living systems. Research in these fields can contribute to foundational knowledge and may inform biomedical, biotechnology, and life-science applications. A detailed account of Liao’s specific contributions requires examination of verified publications, abstracts, methods, findings, and independent evidence of use or influence. This article therefore does not attribute particular discoveries or clinical outcomes without supporting source material.

Publications

The supplied Scopus profile lists 65 documents. A publication-level assessment should consider article titles, publication venues, authorship, dates, research methods, and the relevance of each work to the stated subject area. Individual publication titles and DOI identifiers have not been supplied in the input data, so specific papers cannot be reliably listed here. The Scopus author profile is the appropriate starting point for checking indexed records and available citation details. (1)

Research Impact

Citation counts provide one indication of how often indexed publications are cited by other works. The h-index combines publication output and citation frequency, but its interpretation varies across disciplines, career stages, database coverage, and authorship practices. The reported values of 3,364 citations and an h-index of 31 can inform an initial assessment, but should be considered alongside research quality, reproducibility, collaboration, and broader scholarly or societal relevance. (3)

Award Suitability

The supplied publication and citation indicators may be relevant to consideration for a Best Researcher Award. A balanced evaluation by the International Academic Achievements & Awards should also examine documented research originality, methodological rigor, publication quality, field-specific influence, ethical research practice, and evidence supporting the nominee’s individual contributions. The metrics alone should not be treated as confirmation of an award decision. Eligibility and recognition should be determined according to the event’s published criteria and review process.

Conclusion

Zhiwei Liao’s supplied profile records research activity in Biochemistry, Genetics and Molecular Biology, with an affiliation at Huazhong University of Science and Technology in China. The reported Scopus metrics offer a quantitative overview of scholarly output and citation visibility. For a reliable academic recognition profile, these indicators should be verified against the current Scopus record and considered together with the researcher’s publications, contributions, and supporting evidence. The linked Scopus and ORCID records provide starting points for further verification.

References

  1. Elsevier. (n.d.). Scopus Author Profile: Zhiwei Liao, Author ID 57256472800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57256472800
  2. ORCID. (n.d.). Zhiwei Liao – ORCID Record. ORCID, researcher identifier 0000-0002-6723-2522.
    https://orcid.org/0000-0002-6723-2522
  3. Zhang, W., Li, G., Luo, R., Lei, J., Song, Y., Wang, B., Ma, L., Liao, Z., Ke, W., Liu, H., et al. (2022). Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis. Experimental and Molecular Medicine.
    DOI: https://doi.org/10.1038/s12276-022-00729-9
  4. Ma, L., Li, G., Lei, J., Song, Y., Feng, X., Tan, L., Luo, R., Liao, Z., Shi, Y., Zhang, W., et al. (2022). Nanotopography Sequentially Mediates Human Mesenchymal Stem Cell-Derived Small Extracellular Vesicles for Enhancing Osteogenesis. ACS Nano.
    DOI: https://doi.org/10.1021/acsnano.1c07150
  5. Ma, L., Ke, W., Liao, Z., Feng, X., Lei, J., Wang, K., Wang, B., Li, G., Luo, R., Shi, Y., et al. (2022). Small extracellular vesicles with nanomorphology memory promote osteogenesis. Bioactive Materials.
    DOI: https://doi.org/10.1016/j.bioactmat.2022.01.008

Promise Paul | Biochemistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Promise Paul
Affiliation Michael Okpara University of Agriculture, Umudike
Country Nigeria
Google Scholar ID o4j7GMIAAAAJ
Documents 6
Citations 24
h-index 1
Subject Area Biochemistry
Event International Academic Achievements & Awards
ORCID 0009-0002-7532-8409

Researcher: Promise Paul
Institution: Michael Okpara University of Agriculture, Umudike

Promise Paul is a researcher affiliated with Michael Okpara University of Agriculture, Umudike, Nigeria, whose scholarly activities are centered on biochemistry, toxicology, environmental health, immunology, and emerging public health technologies. His published research demonstrates interdisciplinary collaboration involving biochemical mechanisms, environmental risk assessment, immunomodulation, and artificial intelligence applications in healthcare. Based on the available scholarly record, his work reflects an emphasis on translating laboratory findings into practical biomedical and public health applications.[1][2]

Abstract

Promise Paul has contributed to a growing body of interdisciplinary research spanning biochemical sciences, environmental toxicology, occupational exposure assessment, immunology, and public health. His publications investigate volatile organic compound interactions with biological receptors, bioaccumulation of toxic elements in aquatic organisms, antioxidant mechanisms, immune regulation, and artificial intelligence applications in disease surveillance. Collectively, these studies contribute to understanding disease prevention, environmental safety, and biomedical innovation while supporting evidence-based public health practices.[2][3]

Keywords

Biochemistry, Environmental Toxicology, Occupational Health, Drug Design, Artificial Intelligence, Public Health, Immunology, Oxidative Stress

Introduction

Modern biomedical research increasingly depends on interdisciplinary collaboration to address complex health and environmental challenges. Promise Paul’s research portfolio reflects this approach by integrating biochemical investigation with environmental science, clinical perspectives, and computational technologies. His collaborative publications examine toxicological mechanisms, disease prevention, environmental monitoring, and innovative analytical strategies that support scientific understanding across multiple disciplines.[2]

Research Profile

The available publication record indicates research interests spanning molecular toxicology, pharmacology, environmental biochemistry, immunomodulation, veterinary science, and digital public health. His collaborative studies frequently investigate biological responses to toxic compounds, mechanisms of oxidative stress, environmental contaminants, and innovative approaches for disease surveillance using artificial intelligence technologies. These areas collectively contribute to improving scientific understanding of health risks and preventive strategies.[1]

Research Contributions

  • Investigated volatile organic compound interactions with drug receptors to support rational drug discovery strategies.
  • Contributed to environmental health studies evaluating toxic element bioaccumulation in commercially important fish species.
  • Participated in immunology research examining therapeutic approaches for congenital immunodeficiencies.
  • Co-authored research exploring ethical implementation of artificial intelligence for public health surveillance.
  • Investigated antioxidant effects of L-Arginine against carbon tetrachloride-induced oxidative damage in experimental animal models.

Publications

  1. Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure. Processes, 13(1), 154. DOI: https://doi.org/10.3390/pr13010154
  2. Bioaccumulation and Human Health Risk Assessment of Potentially Toxic Elements in Commercial Fish Species. International Journal of Environmental Research and Public Health, 23(7), 827.
  3. Immunomodulation in Congenital Immunodeficiencies: Targeting Innate and Adaptive Pathways. Clinical Medicine and Integrative Therapies, 1(1), 36–52.
  4. Artificial Intelligence for Public Health Surveillance: Promises, Pitfalls, and an Ethics-Equity Roadmap for Deployment. Disease Prevention and Epidemiology, 1(1), 22–39.
  5. Antioxidant Effects of L-Arginine on Redox Profile of Carbon Tetrachloride (CCl4)-Intoxicated Albino Rats. Journal of Sustainable Veterinary & Allied Sciences, 7(4), 385–391.

Research Impact

Although currently representing an early-stage publication profile, the available scholarly metrics indicate growing visibility through peer-reviewed publications and citations. The interdisciplinary nature of these investigations contributes to knowledge spanning environmental safety, biomedical science, toxicology, and digital health while encouraging collaboration across multiple scientific disciplines.[2]

Award Suitability

Promise Paul’s research portfolio demonstrates characteristics commonly considered for emerging research recognition, including interdisciplinary collaboration, publication in peer-reviewed journals, investigation of contemporary biomedical and environmental issues, and contributions to public health research. The Innovative Research Award appropriately recognizes researchers developing multidisciplinary scientific approaches with potential societal relevance.[1][2]

Conclusion

Promise Paul has established an emerging interdisciplinary research profile focused on biochemistry, environmental health, immunology, toxicology, and artificial intelligence applications in medicine. His collaborative publications demonstrate scientific engagement with important biomedical and environmental challenges, supporting continued academic development and making his work consistent with the objectives of recognizing innovative scientific research.

References

  1. Google Scholar. (n.d.). Promise Paul – Google Scholar Citations Profile.
    https://scholar.google.com/citations?user=o4j7GMIAAAAJ&hl=en&oi=ao
  2. Processes. (2025). Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure.DOI:https://doi.org/10.3390/pr13010154
  3. ORCID. (n.d.). Promise Paul ORCID Record.
    https://orcid.org/0009-0002-7532-8409
  4. Crossref DOI Foundation. (n.d.). DOI Metadata and Scholarly Record Services.

Narendra Verma | Biochemistry | Research Excellence Award

Published on by Academic Achievements

Research Excellence Award

Narendra Verma
Affiliation Centre of BioMedical Research Lucknow
Country India
Scopus ID 57191708464
Documents 18
Citations 1,303
h-index 10
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards

Narendra Verma
Centre of BioMedical Research Lucknow, India

Narendra Verma is an Indian molecular biologist and geneticist currently serving as Assistant Professor in the Department of Systems Biology at the Centre of Biomedical Research (CBMR), Lucknow. His research spans genetics, transcriptomics, metabolic biology, cancer signaling, adipose tissue physiology, and cellular regulatory mechanisms. Through collaborations with leading international laboratories, he has contributed to advances in cancer biology, obesity research, metabolic disorders, and molecular signaling pathways.[1]

Abstract

Narendra Verma has established a multidisciplinary research portfolio focused on molecular genetics, cancer biology, obesity, metabolic disorders, and transcriptomic regulation. His scholarly contributions include highly cited publications in leading journals such as Nature, Cancer Cell, Oncogene, Stem Cells, and Journal of Biological Chemistry. His current work investigates glycophagy-mediated metabolic regulation in diabetes-induced fatty liver disease through an ICMR-funded project.[2]

Keywords

Genetics, Molecular Biology, Transcriptomics, Cell Signaling, Cancer Biology, Obesity, Metabolism, Adipose Tissue, Diabetes, Glycophagy.

Introduction

Following academic training in biotechnology and molecular genetics in India and Italy, Dr. Verma developed expertise in transcriptional regulation, metabolic signaling, and disease mechanisms. His research integrates experimental biology with translational applications aimed at understanding metabolic and oncogenic processes.[3]

Research Profile

His investigations have explored Sox2-mediated tumorigenesis, YAP signaling regulation, adipocyte metabolism, thermogenesis, inflammatory signaling, and metabolic dysfunction. These studies combine cellular, molecular, and genomic approaches to address fundamental biomedical questions.[4]

Research Contributions

  • Identified Sox2-dependent mechanisms in osteosarcoma development.
  • Advanced understanding of YAP signaling in cancer progression.
  • Contributed to landmark Nature research on fungal microbiome-driven pancreatic oncogenesis.
  • Investigated thermogenic and adipocyte regulatory pathways.
  • Leading ICMR-funded studies on glycophagy and fatty liver disease.

Publications

Notable publications include articles in Nature, Cancer Cell, Oncogene, Stem Cells, Aging Cell, ATVB, and Journal of Biological Chemistry. Several publications have appeared in journals with significant impact factors and international visibility.[5]

Research Impact

According to Scopus data, Dr. Verma has accumulated over 1,300 citations across 18 indexed publications with an h-index of 10. His work has influenced research in cancer biology, metabolism, immunology, and molecular medicine, reflecting broad interdisciplinary relevance.[1]

Award Suitability

Dr. Verma demonstrates strong eligibility for research excellence recognition due to his impactful publication record, international collaborations, competitive grant funding, and sustained contributions to molecular and biomedical sciences. His ongoing ICMR-supported research further highlights his active role in advancing translational health research.

Conclusion

The academic achievements of Dr. Narendra Kumar Verma illustrate a productive career focused on understanding the molecular basis of disease. Through influential publications, collaborative science, and funded research programs, he continues to contribute to biomedical innovation and scientific advancement.

References

  1. Elsevier. (2026). Scopus Author Details: Narendra Kumar Verma, Author ID 57191708464.
    https://www.scopus.com/authid/detail.uri?authorId=57191708464
  2. ICMR Project Record. Unraveling the Glycophagy Receptors: Targeting HSF1-STBD1 Axis to Manage Metabolic Homeostasis in Diabetes-Induced Fatty Liver. https://cbmr.res.in/faculty-profile-single.php?qwr=DTM-FCT20#gsc.tab=0
  3. Verma N. et al. Journal of Biological Chemistry. 2020.
  4. Maurizi G., Verma N., et al. Oncogene. 2018.
  5. Aykut B., Pushalkar S., Verma N., et al. Nature. 2019.
    https://doi.org/10.1038/s41586-019-1608-2